Jamie Dananberg

Jamie Dananberg

Director Técnico/Científico/I+D en ANNEXON, INC. .

Fortuna: 522 752 $ al 30/09/2026

68 años
Health Technology
Consumer Services

Perfil

Jamie Dananberg is currently Chief Medical Officer & Executive Vice President at Annexon, Inc. since 2023 and serves as a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, Executive Vice President at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
Education includes undergraduate and doctorate degrees from Tufts University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/03/2026 123.582 ( 0,07 % ) 522 752 $ 30/09/2026

Cargos activos de Jamie Dananberg

EmpresasCargoInicio
ANNEXON, INC. Director Técnico/Científico/I+D 27/07/2023
Director/Miembro de la Junta -

Antiguos cargos conocidos de Jamie Dananberg.

EmpresasCargoFin
UNITY BIOTECHNOLOGY, INC. Director Técnico/Científico/I+D 30/04/2023
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/10/2015
ELI LILLY AND COMPANY Corporate Officer/Principal 01/09/2012
Ver el detalle de la experiencia de Jamie Dananberg.

Formación de Jamie Dananberg.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

74

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology